The UF College of Pharmacy Department of Pharmaceutical Outcomes and Policy welcomes Matthew Kirchoff, Pharm.D., M.S., M.B.A., CPH, BCPS, as our October 4th Guest Speaker.
Matthew Kirchoff, Pharm.D., M.S., M.B.A., CPH, BCPS, is a Commander in the US Public Health Service Commissioned Corps and serves as a Country Co-Lead for Liberia, a position where he shares broad oversight of NIH interests in the PREVAIL clinical research partnership consisting of six research sites and over 300 Liberian staff. He also serves as the Division of Clinical Research’s Clinical Research Operations Manager for International Research Pharmacy Operations, where he manages all pharmacy operations in multi-site, multi-country, multi-stakeholder international clinical investigations, including recent Ebola-related vaccine and treatment trials in Liberia, Sierra Leone, Guinea, and Mali.
Matt previously worked as a Regulatory Program Manager within the Food and Drug Administration’s Office of Medical Policy, where he developed policies and programs to facilitate the use of mobile technologies to conduct clinical trials which are more convenient for participants, have less missing data, and allow for new types of data collection. When first joining the FDA at the Office of Compliance, Matt developed a Market Analysis and Surveillance Tool to identify marketed unapproved prescription drugs, which can also provide immediate information used to prevent drug shortages.
Matt attended the University of Florida (UF) for his BS in Nutrition, Doctor of Pharmacy, MS in Pharmacoepidemiology, and received an MBA from the University of North Carolina at Chapel Hill. Matt is also Certified in Public Health (CPH) and a Board Certified Pharmacotherapy Specialist (BCPS). Matt was recognized in 2013 by UF as one of “Twenty under 30 Gators To Watch,” and in 2016 was selected as a dual Outstanding Young Alumni by his undergraduate and graduate Colleges at the University of Florida. In 2016 he also received the Depart of Health and Human Services Secretary’s Award for Distinguished Service, the highest award issued by the Secretary, as part of NIH’s Ebola Clinical Research Response Team.